China conditionally approves four self-developed COVID-19 vaccines: official
Xinhua |
Updated: 2021-02-26 20:09
Share
Share - WeChat
BEIJING - China has granted conditional market approval to four self-developed COVID-19 vaccines, Minister of Science and Technology Wang Zhigang said Friday.
China has adopted five technological approaches in developing COVID-19 vaccines. China now has 17 self-developed COVID-19 vaccines undergoing clinical trials, with seven undergoing phase-3 clinical trials, Wang told a press conference held in Beijing.
China has also included 11 drugs and treatment methods in its diagnosis and treatment plan for COVID-19, Wang added.
- South China city reports over 1,700 Chikungunya cases
- Xinjiang starts building new expressway linking north and south
- Intl tourists captivated by traditional opera gala in Kunshan
- Training and transport jets showed at Changchun air show
- Dunhuang expo offers a key platform for dialogue among civilizations
- Lora Saalman: Beijing Xiangshan Forum crucial for dialogue amid cybersecurity risks
